To say it is an interesting time to be in the clinical research field might be considered a significant understatement. Between the rapid evolution in data collection and analytical solutions, dynamic changes in different technologies, and the increased adoption of the decentralized clinical trial format (catalyzed in part by the pandemic), there is a lot to keep on top of and learn.
During Outsourcing-Pharma’s upcoming webinar on Clinical Development Advances, a group of well-respected industry professionals will be offering insights on all these changes—and how to stay informed about putting these advances to work in your operation.
Register today for Clinical Development Advances, then join us virtually on March 23 for the live event at 10 am CT (Chicago) | 5 pm CET (Paris). This lively discussion will feature insightful presentations from four leaders:
Adam Kaplin, MD, PhD
Chief Scientific Officer, MyMD Pharmaceuticals
In December 2020, Kaplin was named chief scientific officer of MyMD, a pharma firm specializing in novel treatments targeting aging and age-related diseases; autoimmune diseases; and chronic pain, anxiety, and sleep disorders. He also has served in a number of positions at John Hopkins University, including Principal Neuro-Psychiatric Consultant to the Johns Hopkins Multiple Sclerosis Center of Excellence, Director of the Johns Hopkins Ketamine Clinic, and the Departments of Psychiatry and Neurology at Johns Hopkins University School of Medicine.
Additionally, he has served as Adjunct Faculty at the George Mason University Department of Global and Community Health since 2019. He Kaplin received his B.S. in Biology from Yale University, and his M.D. and Ph.D. from the Johns Hopkins University School of Medicine in 1996.
Co-chair, Decentralized Trials and Research Alliance (DTRA)
Lipset is co-chair for the DTRA, an organization that seeks to foster collaboration of stakeholders on the acceleration of patient-focused DCT and research. He also serves as vice-chair of the MedStar Health Research Institute, and vice president of the Foundation for Sarcoidosis.
He is adjunct assistant professor in health informatics at Rutgers University and founder of Clinical Innovation Partners, providing advisory and board leadership with pharma, tech, and investors. He previously served as head of clinical innovation and venture partner at Pfizer and on the founding management teams for two successful startup ventures.
President CEO, Rafael Pharmaceuticals
Luther is CEO of Rafael Pharmaceuticals, a company that specializes in developing novel therapies for rare and challenging cancers. During his career, he has been credited with significant growth and performance in domestic and international markets; he has led strategies and increased ROI for Fortune 500 and startups, including Bristol-Myers Squibb, Novartis, Bausch and Lomb, GE Healthcare, and Mallinckrodt.
As Rafael’s CEO, he leads all of the company's research and development initiatives, as well as all clinical trial programs. He is also a board member at Lipomedix.
Chief Clinical Trials Officer, Walgreens Boots Alliance
Tandron is the chief clinical trials officer of the Walgreens Boots Alliance, which seeks to improve the quality of and access to healthcare around the globe in numerous ways. She has more than a quarter-century of trial and CRO experience, with past positions including high-level posts as Trio Health, Phesi, ICON, and Inventive Health Commercial.
Tandron works in her current position to help make clinical trial participation more feasible for potential patients across all communities.
Register today and reserve your space for this fascinating, insightful online event, and feel free to share the link with any of your colleagues you feel might benefit from the webinar. If you are busy on the scheduled date and time, don't worry - your registration enables you to go back and view the webinar at your convenience, as soon as the recording is available.